Almost 1:10 adolescents non-prescription weight loss products globally

One in ten adolescents globally have used ineffective and potentially harmful non prescribed weight loss products in their lifetime, with 2% using them in the previous week. A review, of over 90 studies of 600,000+ participants, headed by Ms Natasha Hall fro0m Monash University’s School of Public Health and Preventive Medicine and published in the Journal of the American Medical Association has […]

Diabetes drug appears to prevent substantial weight gain in female ex-smokers

Dulaglutide.  a Type 2 diabetes treatment, appears to significantly lower the risk of weight gain among women who have stopped smoking, researchers reported after a secondary analysis of clinical trial data. They published their findings on Dec. 19, 2023 in BMJ Nutrition Prevention & Health. As background, the authors noted, “Women seem to have more difficulty quitting smoking than men. This […]

Alarm over lax oversight of weight loss drug ads that could harm patients

UK organisations responsible for protecting the public from prescription-only drug adverts are putting patients at risk from the harms of weight loss drugs by not enforcing the law, reveals an investigation published by The BMJ today. Legal responsibility for regulating adverts for medicines in the UK rests with the Medicines and Healthcare products Regulatory Agency (MHRA) on behalf of health ministers. But […]

Tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain

The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within a year. At the same time, the study shows that remaining on the drug not only […]

FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors – Eli Lilly

The FDA approved Eli Lilly and Company’s Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors. Zepbound is indicated for adults with obesity (with a BMI of 30 kg/m2 or greater), or those who are overweight (with a BMI of 27 kg/m2 or greater) […]

Cigarette style warning labels could reduce people’s meat consumption

Cigarette style graphic warning labels could reduce people’s meat consumption, according to new research published today (1 November). The study suggests the use of warning labels on meat options could improve public health and reduce the UK’s carbon footprint. The team from Durham University tested a range of warning labels including those which warn people of the damage to climate, […]

Online grocery shopping promotes less variety, fewer impulse buys

Online grocery carts tend to include less variety and fewer fruits and vegetables than those in a trip to a brick-and-mortar supermarket – but online shoppers are less susceptible to unhealthy impulse buys, according to a new Cornell University study. In an analysis of nearly 2 million shopping trips, the researchers found that within a given household, Instacart baskets are more […]

Study shows simple diet swaps can cut carbon emissions and improve your health

Curbing carbon emissions and eating healthier may both start at the dinner table. According to a new study co-authored by a Tulane University researcher and published in the journal Nature Food, making simple substitutions like switching from beef to chicken or drinking plant-based milk instead of cow’s milk could reduce the average American’s carbon footprint from food by 35%, while also boosting […]

Globally, consumption of sugary drinks increased at least 16% since 1990

The decision to reach for a sugary beverage is heavily influenced by where you live, Friedman School of Nutrition Science and Policy researchers report in a new study published October 3 in the journal Nature Communications. While an analysis of the Global Dietary Database for the years 1990, 2005, and 2018 found overall consumption of sweetened drinks increased—by nearly 16% worldwide over the 28-year period […]

Semaglutide (Ozempic/Wegovy) shows 3-year efficacy for blood sugar control and weight loss

Data from a “real world” study indicates that treatment with the semaglutide (Ozempic/Wegovy) for type 2 diabetes significantly improves both blood sugar control and weight loss for up to 3 years in adults. The findings were released on Oct 2, 2023 from the Annual Meeting of The European Association for the Study of Diabetes (EASD). “Our long-term analysis of semaglutide […]